GREENWICH LIFESCIENCES INC (GLSI)

GLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023

GLSI stock results show that Greenwich LifeSciences missed analyst estimates for earnings per share the fourth quarter of 2023.

GLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Greenwich LifeSciences (NASDAQ:GLSI) just reported results for the fourth quart...

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

STAFFORD, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

STAFFORD, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the

Greenwich LifeSciences stock jumps 8% on Phase 3 study expansion (NASDAQ:GLSI)

Greenwich LifeSciences (GLSI) stock jumped 8% after the biotech company said it has received approval to expand a Phase 3 study of its drug GSLI-100 in Europe. Read more here.

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

STAFFORD, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the

Greenwich Lifesciences announces acceptance for Flamingo-01 trial by EMA (NASDAQ:GLSI)

Greenwich LifeSciences receives approval from European Medicines Agency for expansion of Flamingo-01 clinical trial in Europe, marking a significant...

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

STAFFORD, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the

Greenwich LifeSciences is Now Oversold (GLSI)

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

STAFFORD, Texas, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical...

Top Buys by Top Brass: CFO Patel's $223.6K Bet on GLSI

Relative Strength Alert For Greenwich LifeSciences

Greenwich LifeSciences is Now Oversold (GLSI)

Relative Strength Alert For Greenwich LifeSciences

Greenwich LifeSciences Provides Year End Update

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023

GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This Week

Short-squeeze stocks continue to be a big deal for speculative traders and we're helping them out with a list to keep in mind this week!

TOPS, SURG: The Top 5 Short Squeeze Stocks This Week

Short squeeze stocks are still popular with speculative traders and that has us going over the top ones to keep an eye on this week!

GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week

Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week!

NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week

Traders continue to show interest in short squeeze stocks this week as they seek out likely targets that will run higher.

ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week

We're starting off another week with a deep dive into the short squeeze stocks traders are going to want to keep an eye on!

MICS, REV: The Top 5 Short Squeeze Stocks to Watch This Week

Investors looking for the most likely short squeeze stocks to watch this week are in the right place with a list of the top five to watch!